OTCPK:TRUM.F

Stock Analysis Report

Executive Summary

Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide.

Snowflake

Fundamentals

Flawless balance sheet second-rate dividend payer.


Similar Companies

Share Price & News

How has Terumo's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-2.3%

OTCPK:TRUM.F

-0.9%

US Medical Equipment

1.3%

US Market


1 Year Return

n/a

OTCPK:TRUM.F

9.1%

US Medical Equipment

2.0%

US Market

No trading data on TRUM.F.

No trading data on TRUM.F.


Share holder returns

TRUM.FIndustryMarket
7 Day-2.3%-0.9%1.3%
30 Day-8.2%0.7%3.9%
90 Day-1.9%4.4%3.4%
1 Yearn/a10.0%9.1%4.2%2.0%
3 Year-22.9%-22.9%70.7%65.5%47.2%37.6%
5 Year15.7%15.7%130.7%104.3%60.5%42.9%

Price Volatility Vs. Market

How volatile is Terumo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Terumo undervalued based on future cash flows and its price relative to the stock market?

27.99x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Terumo's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Terumo's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Terumo is good value based on earnings compared to the US Medical Equipment industry average.

Terumo is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Terumo is poor value based on expected growth next year.


Price Based on Value of Assets

Terumo is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Terumo expected to perform in the next 1 to 3 years based on estimates from 12 analysts?

8.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Terumo's revenue is expected to grow by 5.5% yearly, however this is not considered high growth (20% yearly).

Terumo's earnings are expected to grow by 8.4% yearly, however this is not considered high growth (20% yearly).

Terumo's revenue growth is positive but not above the United States of America market average.

Terumo's earnings growth is positive but not above the United States of America market average.

Terumo's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Terumo is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Terumo performed over the past 5 years?

21.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Terumo has delivered over 20% year on year earnings growth in the past 5 years.

Terumo's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Terumo's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.


Return on Equity

Terumo has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Terumo used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Terumo's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Terumo's financial position?


Financial Position Analysis

Terumo is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Terumo's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Terumo's level of debt (32.1%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (35.3% vs 32.1% today).

Debt is well covered by operating cash flow (45.2%, greater than 20% of total debt).

Terumo earns more interest than it pays, coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.7x debt.


Next Steps

Dividend

What is Terumo's current dividend yield, its reliability and sustainability?

1.00%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Terumo's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).

Terumo's dividend is below the markets top 25% of dividend payers in United States of America (3.67%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (4.2x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Terumo's salary, the management and board of directors tenure and is there insider trading?

3.4yrs

Average management tenure


CEO

Shinjiro Sato 0

2.4yrs

Tenure

0

Mr. Shinjiro Sato has been the President and Chief Executive Officer at Terumo Corporation since April 2017 and served as its Managing Executive Officer of Terumo Corporation since April 2015. Mr. Sato ser ...


Management Age and Tenure

3.4yrs

Average Tenure

The tenure for the Terumo management team is about average.


Board Age and Tenure

4.3yrs

Average Tenure

64.5yo

Average Age

The tenure for the Terumo board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • David Perez (60yo)

    Senior Executive Officer & Director

    • Tenure: 5.3yrs
    • Compensation: JP¥298.00m
  • Shinjiro Sato

    President

    • Tenure: 2.4yrs
  • Kyo Nishikawa

    Senior Executive Officer & Chief Human Resources Officer

    • Tenure: 0yrs
  • Ryo Nishihata

    Senior Executive Officer and Chief Accounting & Financial Officer

    • Tenure: 2.7yrs
  • Jim Rushworth

    Executive Officer

    • Tenure: 0yrs
  • Hiroaki Kasukawa

    CTO & Executive Officer

    • Tenure: 0yrs
  • Toshiaki Takagi

    Senior Managing Executive Officer

    • Tenure: 9.3yrs
  • Katsuya Takeuchi

    Chief Information Officer & Executive Officer

    • Tenure: 3.4yrs
  • Miho Mizuguchi

    Executive Officer

    • Tenure: 3.4yrs
  • Atsuo Omagari

    General Manager of Corporate Communication Department

    • Tenure: 0yrs

Board Members

  • David Perez (60yo)

    Senior Executive Officer & Director

    • Tenure: 5.3yrs
    • Compensation: JP¥298.00m
  • Takayoshi Mimura

    Chairman of the Board

    • Tenure: 2.4yrs
  • Ikuo Mori (72yo)

    Independent Director

    • Tenure: 5.3yrs
  • Masatake Yone (65yo)

    Independent Director

    • Tenure: 4.3yrs
  • Shoji Hatano

    Managing Executive Officer & Director

    • Tenure: 3.3yrs
  • Shinjiro Sato

    President

    • Tenure: 2.4yrs
  • Toshihiko Matsumiya

    Independent Director

    • Tenure: 4.3yrs
  • Yoshihiro Kimura (64yo)

    Director

    • Tenure: 2.3yrs
  • Ryuzo Ueda

    Independent Director

    • Tenure: 4.3yrs
  • Toshiaki Takagi

    Senior Managing Executive Officer

    • Tenure: 9.3yrs

Company Information

Terumo Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Terumo Corporation
  • Ticker: TRUM.F
  • Exchange: OTCPK
  • Founded: 1921
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: JP¥2.370t
  • Listing Market Cap: JP¥21.925b
  • Shares outstanding: 743.12m
  • Website: https://www.terumo.co.jp

Number of Employees


Location

  • Terumo Corporation
  • 2-44-1, Hatagaya
  • Shibuya-ku
  • Tokyo
  • 151-0072
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TRUM.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 1992
4543TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYJan 1992
TUODB (Deutsche Boerse AG)YesCommon StockDEEURJan 1992
TRUM.YOTCPK (Pink Sheets LLC)ADRUSUSDOct 2008

Biography

Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 23:49
End of Day Share Price2019/09/12 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.